Relation between early stages of diabetic retinopathy and early stages of diabetic kidney disease in patients with type 2 diabetes in Egypt
Abstract
Background. Diabetes mellitus is a pandemic disease. Type 2 diabetes (T2DM) is the most common type. Diabetic retinopathy (DR) and diabetic kidney disease (DKD) are disabling chronic complications. The relation between both is not yet well-established in T2DM. Egypt is considered one of the top ten countries re- garding the prevalence of diabetes that makes diabetes and its complications a major health problem. This encouraged us to conduct this research.
Materials and methods. The study included 79 patients with T2DM divided into two groups according to the presence of retinopathy. Both groups were subdivided according to urinary albumin to creatinine ratio (UACR) into normoalbuminuric and albuminuric subgroups. Retinopathy group was further subdivided according to severity of retinopathy into mild, moderate and severe non-proliferative DR (NPDR). Statistical analysis was done and relation between the severity of retinopathy and UACR was studied.
Results. Patients with retinopathy had significantly higher diabetes duration and UACR than non retinopathy group. Also in subgroups of normoalbuminuria and albuminuria, retinopathy group was significantly higher regarding the same parameters. On subdividing the retinopathy group according to severity, severe NPDR group had significantly higher UACR. The severity of DR was significantly positively correlated with UACR.
Conclusions. The present study identified a significantly positive correlation between early stages of DR and UACR in patients with T2DM in Egypt. Not all cases of DR had DKD especially in early stages and also not all cases of DKD are associated with the presence of DR in T2DM.
Keywords: diabetic retinopathydiabetic kidney diseasetype 2 diabetes
References
- American Diabetes Association. Standards of medical care in diabetes 2019. Diabetes Care. 2019; 42(Suppl. 1): S1–S2.
- https://www.idf.org/our-network/regions-members/middle-east-and-north-africa/members/34-egypt. html [accessed 13 jan. ; 2019.
- Yau JWY, Rogers SL, Kawasaki R, et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3): 556–564.
- Chew EY, Davis MD, Danis RP, et al. Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 2014; 121(12): 2443–2451.
- American Diabetes Association. 11. Microvascular Complications and Foot Care: . Diabetes Care. 2019; 42(Suppl 1): S124–S138.
- Romero-Aroca P, Mendez-Marin I, Baget-Bernaldiz M, et al. Review of the Relationship between Renal and Retinal Microangiopathy in Diabetes Mellitus Patients. Current Diabetes Reviews. 2010; 6(2): 88–101.
- Collins AJ, Foley RN, Gilbertson DT, et al. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015; 5(1): 2–7.
- Kanauchi M, Kawano T, Uyama H, et al. Discordance between retinopathy and nephropathy in type 2 diabetes. Nephron. 1998; 80(2): 171–174.
- Pham H, Armstrong DG, Harvey C, et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care. 2000; 23(5): 606–611.
- Apelqvist J, Bakker K, van Houtum WH, et al. International Working Group on the Diabetic Foot (IWGDF) Editorial Board. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2008; 24 Suppl 1: S181–S187.
- Stevens LA, Schmid CH, Zhang YL, et al. Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant. 2010; 25(2): 449–457.
- Sanyal D, Chatterjee S. Advanced Diabetic Nephropathy with "Clean" Eyes: An Extreme Phenotype. Indian J Endocrinol Metab. 2018; 22(2): 274–276.
- He F, Xia X, Wu XF, et al. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia. 2013; 56(3): 457–466.
- Kotlarsky P, Bolotin A, Dorfman K, et al. Link between retinopathy and nephropathy caused by complications of diabetes mellitus type 2. Int Ophthalmol. 2015; 35(1): 59–66.
- Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, et al. Glomerular Filtration Rate and/or Ratio of Urine Albumin to Creatinine as Markers for Diabetic Retinopathy: A Ten-Year Follow-Up Study. Journal of Diabetes Research. 2018; 2018: 1–9.
- Zhang J, Wang Y, Li Li, et al. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy. Ren Fail. 2018; 40(1): 243–251.
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865): 813–820.
- Hu QR, Huang LZ, Chen XL, et al. Genetic analysis and clinical features of X-linked retinoschisis in Chinese patients. Sci Rep. 2017; 7: 44060.
- Abhary S, Hewitt AW, Burdon KP, et al. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes. 2009; 58(9): 2137–2147.
- Uthra S, Raman R, Mukesh BN, et al. Diabetic retinopathy: Validation study of ALR2, RAGE, iNOS and TNFB gene variants in a south Indian cohort. Ophthalmic Genet. 2010; 31(4): 244–251.
- Cilenšek I, Mankoč S, Petrovič MG, et al. GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy. Dis Markers. 2012; 32(2): 93–99.